339 related articles for article (PubMed ID: 21446989)
1. Immunohistochemical staining with Melan-A of uninvolved sun-damaged skin shows features characteristic of lentigo maligna.
Bowen AR; Thacker BN; Goldgar DE; Bowen GM
Dermatol Surg; 2011 May; 37(5):657-63. PubMed ID: 21446989
[TBL] [Abstract][Full Text] [Related]
2. Comparison of MITF and Melan-A Immunohistochemistry During Mohs Surgery for Lentigo Maligna-Type Melanoma In Situ and Lentigo Maligna Melanoma.
Christensen KN; Hochwalt PC; Hocker TL; Roenigk RK; Brewer JD; Baum CL; Otley CC; Arpey CJ
Dermatol Surg; 2016 Feb; 42(2):167-75. PubMed ID: 26771682
[TBL] [Abstract][Full Text] [Related]
3. Reflectance confocal microscopy of facial lentigo maligna and lentigo maligna melanoma: a preliminary study.
Ahlgrimm-Siess V; Massone C; Scope A; Fink-Puches R; Richtig E; Wolf IH; Koller S; Gerger A; Smolle J; Hofmann-Wellenhof R
Br J Dermatol; 2009 Dec; 161(6):1307-16. PubMed ID: 19566662
[TBL] [Abstract][Full Text] [Related]
4. Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision.
Huilgol SC; Selva D; Chen C; Hill DC; James CL; Gramp A; Malhotra R
Arch Dermatol; 2004 Sep; 140(9):1087-92. PubMed ID: 15381549
[TBL] [Abstract][Full Text] [Related]
5. Staged excision for lentigo maligna and lentigo maligna melanoma: A retrospective analysis of 117 cases.
Hazan C; Dusza SW; Delgado R; Busam KJ; Halpern AC; Nehal KS
J Am Acad Dermatol; 2008 Jan; 58(1):142-8. PubMed ID: 18029055
[TBL] [Abstract][Full Text] [Related]
6. Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma.
Malhotra R; Chen C; Huilgol SC; Hill DC; Selva D
Ophthalmology; 2003 Oct; 110(10):2011-8. PubMed ID: 14522781
[TBL] [Abstract][Full Text] [Related]
7. Collision of malignant melanoma (lentigo maligna type) with squamous cell carcinoma in solar-damaged skin of the face.
Ahlgrimm-Siess V; Hofmann-Wellenhof R; Zalaudek I; Cerroni L; Kerl H
Dermatol Surg; 2007 Jan; 33(1):122-4. PubMed ID: 17214694
[No Abstract] [Full Text] [Related]
8. Management of lentigo maligna and lentigo maligna melanoma: seminars in surgical oncology.
Arlette JP; Trotter MJ; Trotter T; Temple CL
J Surg Oncol; 2004 Jul; 86(4):179-86. PubMed ID: 15221924
[TBL] [Abstract][Full Text] [Related]
9. Histologic similarities between lentigo maligna and dysplastic nevus: importance of clinicopathologic distinction.
Farrahi F; Egbert BM; Swetter SM
J Cutan Pathol; 2005 Jul; 32(6):405-12. PubMed ID: 15953373
[TBL] [Abstract][Full Text] [Related]
10. Double Immunohistochemical Labelling of PRAME and Melan A in Slow Mohs Biopsy Margin Assessment of Lentigo Maligna and Lentigo Maligna Melanoma.
Salih R; Ismail F; Orchard GE
Br J Biomed Sci; 2024; 81():12319. PubMed ID: 38566933
[No Abstract] [Full Text] [Related]
11. Lentigo maligna and lentigo maligna melanoma.
Cohen LM
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):913. PubMed ID: 9204053
[No Abstract] [Full Text] [Related]
12. Geometric staged excision for the treatment of lentigo maligna and lentigo maligna melanoma: a long-term experience with literature review.
Abdelmalek M; Loosemore MP; Hurt MA; Hruza G
Arch Dermatol; 2012 May; 148(5):599-604. PubMed ID: 22782151
[TBL] [Abstract][Full Text] [Related]
13. [Dubreuilh melanoma: and epidemiologic and prognostic study].
Tournillac I; Picot MC; Dereure O; Guilhou JJ; Guillot B
Ann Dermatol Venereol; 1999 Oct; 126(10):676-80. PubMed ID: 10604003
[TBL] [Abstract][Full Text] [Related]
14. Surgical and histologic pitfalls in the management of lentigo maligna melanoma.
Situm M; Buljan M
G Ital Dermatol Venereol; 2012 Feb; 147(1):21-7. PubMed ID: 22370566
[TBL] [Abstract][Full Text] [Related]
15. Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type.
Tannous ZS; Lerner LH; Duncan LM; Mihm MC; Flotte TJ
Hum Pathol; 2000 Jun; 31(6):705-8. PubMed ID: 10872664
[TBL] [Abstract][Full Text] [Related]
16. Amelanotic lentigo maligna melanoma of the face: a case report and review of the literature.
Cliff S; Otter M; Holden CA
Clin Exp Dermatol; 1997 Jul; 22(4):177-9. PubMed ID: 9499607
[TBL] [Abstract][Full Text] [Related]
17. Expression of soluble adenylyl cyclase in lentigo maligna: use of immunohistochemistry with anti-soluble adenylyl cyclase antibody (R21) in diagnosis of lentigo maligna and assessment of margins.
Magro CM; Yang SE; Zippin JH; Zembowicz A
Arch Pathol Lab Med; 2012 Dec; 136(12):1558-64. PubMed ID: 23194049
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous occurrence of multiple melanoma in situ on sun-damaged skin (lentigo maligna), solar lentigo and labial melanosis: the value of dermoscopy in diagnosis.
Massi D; Nardini P; De Giorgi V; Carli P
J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):193-7. PubMed ID: 10642055
[TBL] [Abstract][Full Text] [Related]
19. Review of management and outcome in 65 patients with lentigo maligna.
Al-Niaimi F; Jury CS; McLaughlin S; Herd RM
Br J Dermatol; 2009 Jan; 160(1):211-3. PubMed ID: 19014402
[No Abstract] [Full Text] [Related]
20. PRAME immunohistochemistry as an adjunct for diagnosis and histological margin assessment in lentigo maligna.
Gradecki SE; Valdes-Rodriguez R; Wick MR; Gru AA
Histopathology; 2021 Jun; 78(7):1000-1008. PubMed ID: 33280156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
